GLS1 inhibitor

  • 1 lab in 1 country
  • Cells1

Outcomes

4

SCX

upin human cells1

1 study
  1. GLS1 inhibitor increases SCX in human cells.

    “The mRNA expression of the tendon markers, type 1 collagen, Mohawk and SCX were increased by the GLS1 inhibitor.”

    Cellsrotator cuff-derived cells48 h

    Effects of glutaminase 1 inhibitor on rotator cuff derived cells: a preliminary report in 12 patients

    BMC musculoskeletal disorders8 Oct 2025

More on SCX

IL-6

downin human cells1

1 study
  1. GLS1 inhibitor decreases IL-6 in human cells.

    “The mRNA expression levels of GLS1, IL-6, p16 and p21 were decreased by the GLS1 inhibitor.”

    Cellsrotator cuff-derived cells48 h

    Effects of glutaminase 1 inhibitor on rotator cuff derived cells: a preliminary report in 12 patients

    BMC musculoskeletal disorders8 Oct 2025

More on IL-6

CDKN2A

downin human cells1

1 study
  1. GLS1 inhibitor decreases CDKN2A in human cells.

    “The mRNA expression levels of GLS1, IL-6, p16 and p21 were decreased by the GLS1 inhibitor.”

    Cellsrotator cuff-derived cells48 h

    Effects of glutaminase 1 inhibitor on rotator cuff derived cells: a preliminary report in 12 patients

    BMC musculoskeletal disorders8 Oct 2025

More on CDKN2A

Cell viability

upin human cells1

1 study
  1. GLS1 inhibitor increases cell viability in human cells.

    “Cell viability was significantly decreased by IL-1β loading and increased by the GLS1 inhibitor.”

    Cellsrotator cuff-derived cells48 h

    Effects of glutaminase 1 inhibitor on rotator cuff derived cells: a preliminary report in 12 patients

    BMC musculoskeletal disorders8 Oct 2025

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months